SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 15.67 |
| Enterprise Value ($M) | 11.67 |
| Book Value ($M) | 8.59 |
| Book Value / Share | 0.18 |
| Price / Book | 1.82 |
| NCAV ($M) | -0.68 |
| NCAV / Share | -0.01 |
| Price / NCAV | -23.21 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.27 |
| Return on Assets (ROA) | -1.22 |
| Return on Equity (ROE) | -1.79 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.84 |
| Current Ratio | 1.84 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6.70 |
| Assets | 15.97 |
| Liabilities | 7.38 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | BIOS Fund II, LP | 23.10 | 0.00 | |
| 13G | Hirschman Orin | 9.30 | 188.60 | |
| 13G/A | Ho William Tai-Wei | 7.10 | 7.78 | |
| 13G/A | Transcend Partners Opportunity Fund I LLC | 7.50 | -21.63 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 157,628 | 522,743 | 30.15 | |
| 111,512 | 422,775 | 26.38 | |
| 184,587 | 566,145 | 32.60 | |
| 145,474 | 409,056 | 35.56 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| HROW – Harrow, Inc. | IKNA – Ikena Oncology, Inc. |
| IMRX – Immuneering Corporation | IOVA – Iovance Biotherapeutics, Inc. |
| IPA – ImmunoPrecise Antibodies Ltd. |
Financial data and stock pages provided by
Fintel.io